Hyperhomocysteinemia is a risk factor of middle cerebral artery stenosis

Journal of Neurology

Volumn 254, Issue 3, 2007, Pages 364-367

  Huang, Hai Wei ^a   Guo, Ming Hui ^a   Lin, Rui Jin ^b   Chen, Ya Li ^b   Luo, Qin ^b   Zhang, Ying ^b   Wong, Ka Sing ^c  

^a SUN YAT SEN UNIVERSITY   (China)

^b Rongqi Hospital of Shunde   (China)

^c CHINESE UNIVERSITY OF HONG KONG   (Hong Kong)

Author keywords

Cerebral artery; Homocysteine; Hypertension; Transcranial doppler

Indexed keywords

HOMOCYSTEINE;

ADULT; AGED; ARTICLE; CHEMICAL ANALYSIS; CHINESE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DATA ANALYSIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; FEMALE; FLUORESCENCE; HUMAN; HYPERHOMOCYSTEINEMIA; HYPERTENSION; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEASUREMENT; MIDDLE CEREBRAL ARTERY; MIDDLE CEREBRAL ARTERY OCCLUSION; PRIORITY JOURNAL; RISK FACTOR; SYSTOLIC BLOOD PRESSURE;

AGED; BLOOD PRESSURE; CARDIOVASCULAR DISEASES; CHI-SQUARE DISTRIBUTION; CHINA; FEMALE; HUMANS; HYPERHOMOCYSTEINEMIA; LOGISTIC MODELS; MALE; MIDDLE AGED; MIDDLE CEREBRAL ARTERY; RISK FACTORS; SEX FACTORS; TRIGLYCERIDES; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 33947159122     PISSN: 03405354     EISSN: 14321459     Source Type: Journal    
DOI: 10.1007/s00415-006-0377-7     Document Type: Article

References (12)

1. Boushey CJ, Beresford SA, Omenn GS, Motulsky AG (1995) A quantitative assessment of plasma homocysteine as a risk factor for vascular disease: probable benefits of increasing folic acid intakes. JAMA 274:1049-1057
2. Christen WG, Ajani UA, Glynn RJ, Hennekens CH (2000) Blood levels of homocysteine and increased risks of cardiovascular disease. Causal or casual? Arch Intern Med 160:422-434
3. Clarke R, Daly L, Robinson K, Naughten E, Cahalane S, Fowler B, Graham I (1991) Hyperhomocysteinemia: an independent risk factor for vascular disease. N Engl J Med 324:1149-1155
4. Fassbender K, Mielke O, Bertsch T, Nafe B, Froschen S, Hennerici M (1999) Homocysteine in cerebral macroangiography and microangiopathy. Lancet 353:1586-1587
5. Hogervorst E, Ribiero HM, Molyneux A, Budge M, Smith D (2002) Plasmahomocysteine levels, cerebrovascular risk factors, and cerebral white matter changes (leukoaraiosis) in patients with Alzheimer disease. Arch Neurol 59:787-793
6. Huang YN, Gao S, Wang LC (1997) Comparison of transcranial Doppler ultrasonography and cerebral angiography in evaluation of occlusive cerebovascular disease. Chinese J Neurol 30:98-101
7. Malinow MR, Bostom AG, Krauss RM (1999) Homocyst(e)ine, diet, andcardiovascular diseases. A statement for healthcare professionals from the nutrition committee. Am Heart Assoc, AHA Sci Advis 99:178-182
8. Moller J, Nielsen GM, Tvedegaard KC, Andersen NT, Jorgensen PE (2000) A meta-analysis of cerebrovascular disease and hyperhomocysteinaemia. Scand J Clin Lab Invest 60:491-500
9. Reutens S, Sachdev P (2002) Homocysteine in neuropsychiatric disorders of the elderly. Int J Geriatr Psychiatry 17:859-864
10. Stein JH, McBride PE (1998) Hyperhomocysteinemia and atherosclerotic vascular disease: pathophysiology, screening and treatment. Arch Intern Med 158:1301-1306
11. Welch GN, Loscalzo J (1998) Mechanisms of disease: homocysteine and atherosclerosis. N Engl J Med 338:1042-1050
12. Wong KS, Huang YN, Gao S, Lam WW, Chan YL, Kay R (1998) Intracranial stenosis in Chinese patients with acute stroke. Neurology 50:812-813